LARIMAR THERAPEUTICS INC (LRMR) Forecast, Price Target & Analyst Ratings

NASDAQ:LRMRUS5171251003

Current stock price

5.09 USD
0 (0%)
At close:
5.0707 USD
-0.02 (-0.38%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LARIMAR THERAPEUTICS INC (LRMR).

Forecast Snapshot

Consensus Price Target

Price Target
$16.97
+ 233.38% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
-$0.57
Revenue Estimate

ChartMill Buy Consensus

Rating
89.41%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.97
Upside
+ 233.38%
From current price of $5.09 to mean target of $16.97, Based on 17 analyst forecasts
Low
$7.07
Median
$16.32
High
$27.30

Price Target Revisions

1 Month
9.45%
3 Months
0.00%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for LRMR. The average price target is 16.97 USD. This implies a price increase of 233.38% is expected in the next year compared to the current price of 5.09.

Analyst Ratings & History

Current Analyst Ratings

LRMR Current Analyst RatingLRMR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

LRMR Historical Analyst RatingsLRMR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
89.41%
LRMR was analyzed by 17 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about LRMR.
In the previous month the buy percentage consensus was at a similar level.
LRMR was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-20WedbushMaintains Outperform -> Outperform
2026-03-03WedbushMaintains Outperform -> Outperform
2026-02-25WedbushReiterate Outperform -> Outperform
2026-02-25CitigroupMaintains Buy -> Buy
2025-10-02OppenheimerMaintains Outperform -> Outperform
2025-09-30WedbushMaintains Outperform -> Outperform
2025-09-30BairdMaintains Outperform -> Outperform
2025-08-19JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-08-15JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-06-25GuggenheimReiterate Buy -> Buy
2025-06-24GuggenheimReiterate Buy -> Buy
2025-06-24WedbushMaintains Outperform -> Outperform
2025-03-25GuggenheimReiterate Buy -> Buy
2025-03-25BairdMaintains Outperform -> Outperform
2025-03-25HC Wainwright & Co.Maintains Buy -> Buy
2025-01-29Truist SecuritiesInitiate Buy
2025-01-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-31HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-16OppenheimerInitiate Outperform
2024-10-03WedbushInitiate Outperform
2024-10-02HC Wainwright & Co.Initiate Buy
2024-09-12Jones TradingInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
-$0.57
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-23.07%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-15.21%
EPS (3 Months)
-11.25%

Next Earnings Summary

LRMR is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is -0.57 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LRMR revenue by date.LRMR revenue by date.
N/AN/A
1,816.14%
N/A
269.02%
N/A
33.54%
N/A
76.37%
N/A
2.57%
N/A
-23.80%
N/A
5.91%
EBITDA
YoY % growth
LRMR ebitda by date.LRMR ebitda by date.
-73.743M-58.013M
21.33%
-52.811M
8.97%
-60.861M
-15.24%
-39.838M
34.54%
-42.649M
-7.06%
-50.139M
-17.56%
-36.208M
27.78%
-41.447M
-14.47%
-90.572M
-118.52%
-172.147M
-90.07%
N/A
10.35%
N/A
2.94%
N/A
58.69%
N/A
256.42%
N/A
244.55%
N/A
58.36%
N/A
18.58%
N/A
EBIT
YoY % growth
LRMR ebit by date.LRMR ebit by date.
-73.813M-58.225M
21.12%
-52.999M
8.98%
-61.122M
-15.33%
-40.101M
34.39%
-42.804M
-6.74%
-50.465M
-17.90%
-36.526M
27.62%
-41.758M
-14.32%
-90.89M
-117.66%
-172.497M
-89.79%
N/A
-4.47%
N/A
5.24%
N/A
81.16%
N/A
656.80%
N/A
179.66%
N/A
-22.87%
N/A
18.74%
N/A
-28.91%
Operating Margin
LRMR operating margin by date.LRMR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
LRMR eps by date.LRMR eps by date.
-33.24-25.44
23.47%
-22.92
9.91%
-23.40
-2.09%
-13.20
43.59%
-3.94
70.15%
-2.97
24.62%
-1.54
48.15%
-0.85
44.81%
-1.30
-52.94%
-2.21
-70.00%
N/A
15.45%
N/A
16.13%
N/A
12.78%
N/A
-32.09%
N/A
29.94%
N/A
33.87%
N/A
47.56%
N/A
53.49%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
-0.57
-23.07%
-0.49
-19.63%
-0.47
23.02%
-0.48
34.12%
-0.57
-0.54%
-0.12
74.98%
-0.53
-12.15%
-0.48
-0.53%
-0.49
13.62%
-0.43
-249.87%
-0.32
39.19%
-0.30
38.82%
Revenue
Q2Q % growth
82.224M12.478M16.993MN/AN/AN/AN/A
EBITDA
Q2Q % growth
-40.069M
-28.84%
-43.469M
-57.40%
-46.453M
5.65%
-51.287M
19.45%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-55.944M
-79.38%
-49.937M
-79.68%
-48.934M
1.14%
-50.973M
20.38%
N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LRMR Yearly Revenue VS EstimatesLRMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
LRMR Yearly EPS VS EstimatesLRMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.38%
EPS Next 5 Year
7.38%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
17.00%
EBIT Next 5 Year
32.91%

LARIMAR THERAPEUTICS INC / LRMR Forecast FAQ

What is the price target for LRMR stock?

17 analysts have analysed LRMR and the average price target is 16.97 USD. This implies a price increase of 233.38% is expected in the next year compared to the current price of 5.09.

What is the next earnings date for LRMR stock?

LARIMAR THERAPEUTICS INC (LRMR) will report earnings on 2026-04-28, after the market close.

What are the consensus estimates for LARIMAR THERAPEUTICS INC (LRMR) next earnings?

The consensus EPS estimate for the next earnings of LARIMAR THERAPEUTICS INC (LRMR) is -0.57 USD and the consensus revenue estimate is 0 USD.

How many analysts cover LARIMAR THERAPEUTICS INC (LRMR) stock?

The number of analysts covering LARIMAR THERAPEUTICS INC (LRMR) is 17.